Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection?

Savvoula Savvidou1, Emmanouil Kalogiannis1, Kalliopi Tsakiri1

  • 11st Department of Internal Medicine, "Papageorgiou" General Hospital of Thessaloniki, Greece.

Insights

This case highlights a rare reactivation of Staphylococcus aureus infection after 53 years, presenting as severe pyomyositis. It underscores the possibility of latent staphylococcal infections, even without typical risk factors.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Staphylococcal pyomyositis is a serious soft tissue infection with significant mortality.
  • It is increasingly diagnosed in non-tropical regions.
  • Predisposing factors usually include skin breaches or weakened immunity.

Observation:

  • A 59-year-old immunocompetent woman presented with primary, community-acquired iliopsoas muscle pyomyositis.
  • The infection rapidly progressed, causing septic pulmonary emboli within 24 hours of admission.
  • Computed tomography-guided drainage and cultures confirmed methicillin-susceptible Staphylococcus aureus.

Findings:

  • The patient had no apparent predisposing factors for infection.
  • A history of staphylococcal osteomyelitis in the same region 53 years prior was noted.
  • Reactivation of the latent staphylococcal infection was hypothesized as the cause.

Implications:

  • This case suggests that staphylococcal infections can remain latent for decades.
  • Further research is needed to understand the mechanisms of reactivated staphylococcal infections.
  • Clinicians should consider latent infections in atypical presentations, even without current risk factors.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39